Pharmaceutical, biotech and medical device companies

Connect with us

For data partners

Product

Resources

TRAVERSE

Data insights

info@traverse.health
+31 6 4186 7545

Cookies managing

Cookie Settings

Cookies necessary for the correct operation of the site are always enabled.
Other cookies are configurable.

Essential cookies

Always On. These cookies are essential so that you can use the website and use its functions. They cannot be turned off. They're set in response to requests made by you, such as setting your privacy preferences, logging in or filling in forms.

Analytics cookies

Disabled

These cookies collect information to help us understand how our Websites are being used or how effective our marketing campaigns are, or to help us customise our Websites for you. See a list of the analytics cookies we use here.

Advertising cookies

Disabled

These cookies provide advertising companies with information about your online activity to help them deliver more relevant online advertising to you or to limit how many times you see an ad. This information may be shared with other advertising companies. See a list of the advertising cookies we use here.

Pharmaceutical, Biotech and Medical device Companies

Product

Main

Pharmaceutical, Biotech and Medical device Companies

For decades clinical trials data has been the gold standard for decision making in healthcare. However, this practice is currently changing towards increased use of the real world data.

This shift is helping us to better understand the unmet medical needs, patient journey, define marketing strategy, support clinical decisions and more.

Value Based Healthcare (VBHC) solutions to assess patient outcomes

WHO reports that almost 10% of global GDP is spent on healthcare. So how to measure efficiency of this expenditure? Value based healthcare concept that is centered at the patients’ outcomes is one of the probable answers. It is the wide spread of EMR and EHR systems and resulted accumulation of real world data that really brings VBHC to life and allows to provide in depth analysis of treatments value.

Regulatory decision-making support

Now regulators around the world start recognizing the potential and importance of this data for regulatory questions at hand. Growing reliability and relevance of RWD allows it to become a vital instrument in consideration for both pre- and post-market decisions.

Market access strategies

Access to real world data can help understand current situation in specific geographies of interest regarding disease prevalence, treatment and prescription patterns. Traverse platform allows for regular updates with understanding campaign dynamics.

Personalized medicine

RWD can be used to identify genetic and molecular markers that predict response to drugs, which can be used to personalize treatment options.